Clinical Trial Update: Expanded Access Program (EAP) of Levacetylleucine for Ataxia-Telangiectasia (A-T)

View source ↗

Summary

IntraBio reports that an Expanded Access Program for Levacetylleucine is available for patients with Ataxia-Telangiectasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Drugs mentioned

• Levacetylleucine (levacetylleucine)

Snippet

Sponsor: IntraBio Inc | Conditions: Ataxia-Telangiectasia (A-T) | Status: AVAILABLE